FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics



Share

Listen

(2 min)



Share

Listen

(2 min)

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
AcquisitionsAcquisitions/MergersAcquisitions/Mergers/ShareholdingsAmgenAmgensAMGNAnti-Competition IssuesBillionBiopharmaceuticalsBiotechnology ServicesBlockBusinessC&E Executive News FilterC&E Industry News FilterContent TypescorporateCorporate Actionscorporate crimeCorporate Crime/Legal ActionCorporate/Industrial NewscrimeCrime/Legal ActionCVSCVS CaremarkCVS HealthDealdrug storesFactiva Filtersftcgeneral newsgovernment policyhealthcareHealthcare Support ServicesHealthcare/Life SciencesHorizonHorizon TherapeuticsHZNPindustrial newsLatestlegal actionlife sciencesMarketmergersMovesOwnership ChangesPharmaceuticalspharmaciesPharmacies/Drug StoresPharmacy Benefit ManagementpoliticalPolitical/General NewsregulationRegulation/Government PolicyretailRetail/WholesaleshareholdingsSpecialty RetailingSYNDTherapeuticsWholesaleWSJ-PRO-WSJ.comwsjhealth
Comments (0)
Add Comment